Cannabis business valuation

How is a cannabis business valued?

In four layers. Most disagreements about price come from mixing them up.

1. Operating value. What the cash flow is worth: normalized earnings times a multiple, tested against after-tax cash.
2. License value. Any premium a buyer pays because the license is scarce and transferable. In open-license states this layer is close to zero.
3. Real estate value. Owned property is valued separately at a market rent and capitalization rate, not folded into the business multiple.
4. Adjustments. Debt, unpaid taxes, deferred capital spending, inventory above or below a normal level, and working capital.

Add the first three, subtract the fourth, and you have equity value. Then remember that value is only realized if a buyer who can pass regulatory review will pay it. A number no approvable buyer will meet is not a valuation. It is a wish.

Which valuation methods work for cannabis?

Method	Where it fits	Cannabis-specific weakness
EBITDA multiple	Profitable businesses with a manager; company buyers	EBITDA ignores 280E, so the same multiple means very different cash returns
SDE multiple	Owner-operated single store or small grow sold to an individual	Must subtract a market wage before comparing with EBITDA multiples
After-tax cash flow multiple	Any adult-use business; how disciplined buyers actually think	Requires a credible tax computation, including the medical and adult-use split
Discounted cash flow	Ramp-ups, turnarounds, new markets	Highly sensitive to wholesale price, tax, and discount-rate assumptions
Revenue multiple	Quick screening; headline deal comparisons	Ignores margin; reported deals span about 0.2x to 0.9x
Asset or liquidation value	Loss-making businesses; distressed sales; the floor in any negotiation	Specialised equipment and build-out recover little; the license may not be saleable separately
Per-unit metrics	Cultivation (per square foot of canopy, per pound of capacity)	Meaningless without cost per pound and current wholesale price

The right method depends on the license. Retail is an earnings business. Cultivation is a cost-position business. Manufacturing depends on brands and contracts. Each is worked through on valuation methods by license type, with detail for dispensaries, cultivation, and manufacturing and extraction.

Whatever the method, the earnings figure has to be normalized first. Remove one-time costs, replace owner pay with a market wage, put related-party rent at a market level, and add back nothing a buyer will actually have to spend. How to read and recast the statements is in cannabis financial statements under 280E.

What multiples are buyers paying in 2026?

There is no database of private cannabis sales. The evidence that can be checked is public trading multiples and announced deal prices.

Public operators. Viridian Capital Advisors reported in November 2025 that 11 U.S. multi-state operators with market caps above $100 million traded at a median 5.1x enterprise value to 2026 EBITDA, or 5.72x on its lease- and tax-adjusted measure. In June 2024 the same group was at 7.8x forward EBITDA. Public operators are the most frequent strategic buyers, and they seldom pay more for your earnings than investors pay for theirs.

Private businesses. Trade commentary, such as Collateral Base’s February 2026 guide, puts single-store dispensaries at 3x to 6x normalized EBITDA. That is commentary, not a survey, and the low end applies in oversupplied markets.

Announced deals, 2025 to 2026.

Deal	Headline	Rough metric
Vireo Growth / PharmaCann Colorado (signed Dec 2025, closed Aug 2026)	Vireo shares valued at $49.0 million, plus assumed liabilities, for the assets of 17 leased dispensaries	About $2.9 million per store in shares, before assumed liabilities; stores leased
TerrAscend, New Jersey (Jul 2026)	$9 million, including a $3 million convertible note, for one store with more than $10 million annualized revenue	Up to about 0.9x revenue
Grown Rogue / PharmaCann New York (Aug 2026)	Anticipated price of about $4.5 million for four dispensaries plus a cultivation and manufacturing facility	Roughly 0.2x retail revenue; distressed seller

Two lessons. Scarcity and distress explain more of the spread than operating quality does. And almost none of these prices were all cash, so compare any multiple on a cash-equivalent basis.

280E versus Schedule III: the arithmetic

Section 280E disallows deductions and credits for a business trafficking in Schedule I or II substances, leaving only cost of goods sold. Since 28 April 2026, marijuana under a state medical license is in Schedule III and outside 280E. Adult-use marijuana remains Schedule I. Dual operators must apportion.

Illustrative. One store: $5,000,000 revenue, $2,250,000 gross profit, $1,500,000 operating expenses, $750,000 EBITDA, 21% federal rate, state tax and depreciation ignored.

Scenario	Taxable income	Federal tax	After-tax cash
Adult-use only (280E applies)	$2,250,000	$472,500	$277,500
40% medical, 60% adult-use, expenses apportioned by revenue	$1,650,000	$346,500	$403,500
Medical only (Schedule III, ordinary deductions)	$750,000	$157,500	$592,500

The apportioned row allows 40% of the $1,500,000 of expenses, or $600,000. Treasury has said it will issue apportionment guidance; revenue share is used here only to show the mechanics.

Now apply one price to all three. At 4x EBITDA the store is $3,000,000. That is 10.8x after-tax cash for the adult-use store, 7.4x for the dual operator, and 5.1x for the medical store. Same EBITDA multiple, very different deals. This is why two businesses with identical EBITDA get different offers, and why sellers with medical sales need books that separate the two activities.

The valuation mechanics are on how 280E affects valuation. What broader rescheduling would and would not change is on how rescheduling would affect valuation. As of mid-September 2026 the DEA hearing on adult-use had ended with no recommendation issued and no deadline. You can run your own figures in the 280E effective tax rate calculator and the rescheduling impact calculator.

What is the license itself worth?

Only what it would cost a buyer, in money and time, to get the same permission another way. Where the state or city caps supply, that can be a great deal. Where anyone qualified can apply, it is close to the application cost.

Market type	Data point	Meaning
Capped, vertically integrated	Planet 13 paid $55 million for a Florida license in 2021, then agreed in January 2024 to sell it for $9 million	The license is the asset, and the premium can collapse. Florida added licenses in September 2026 (details on the capped vs uncapped page linked below).
Capped adult-use retail	An Illinois social equity founder reported selling its retail license for more than $2.5 million in 2024, after the buyer had built and run the store since October 2023 under a management agreement	A seller-reported price for an operating store in a capped market, not for bare paper; Illinois allows the sale only once the store operates
Open license, municipal caps	Michigan had 845 active adult-use retailers on 31 August 2026 and retail flower averaging $60.33 an ounce that month	State license worth little; local approval at a specific address is the scarce asset

Test license value with four questions. Can a buyer apply directly today? Is there a local cap at this address? Is the license transferable now, and to whom? Is more supply coming? The evidence by state is on license value in capped vs uncapped states, and licenses that have never operated are covered on valuing a pre-revenue license. Falling wholesale prices work against every layer of value; see how oversupply and price compression affect value.

How real estate changes the number

Value owned real estate separately, and charge the business a market rent first. Skipping that step double counts.

Illustrative. An owner-operator owns the building and charges no rent. Reported EBITDA is $750,000. Market rent would be $150,000.

Step	Right way	Wrong way
Business EBITDA	$600,000 after market rent	$750,000 with no rent
Business value at 4x	$2,400,000	$3,000,000
Building at an assumed 10% cap rate on $150,000 rent	$1,500,000	$1,500,000
Total	$3,900,000	$4,500,000

The wrong way overstates value by $600,000, which is the rent multiplied by 4. The 10% cap rate is a placeholder for arithmetic, not a market quote.

Leased property matters too. A long lease with a cannabis use clause and assignment rights protects the cash flow being valued. A short lease, or a landlord who can refuse a change of control, puts all of it at risk. See how real estate control affects value and cannabis property values and cap rates.

Compliance, tax debts, and other adjustments

These rarely change the multiple. They change the price, the structure, or whether there is a deal.

• Compliance history. Open investigations can delay or block an ownership-change application, so buyers discount for time as well as fines. See how compliance history affects value.
• Tax liabilities. Unpaid excise, sales, and 280E-era income tax are deducted from price or covered by holdbacks. In an equity sale they transfer with the company.
• Debt and leases. Enterprise value less debt equals equity value. Sale-leaseback rent obligations behave like debt even when the balance sheet does not show them.
• Deferred capital spending. Worn lighting, HVAC, or extraction equipment is a price reduction waiting to be found.

Valuing a distressed cannabis business

Distressed value is set by what a forced sale clears, not by past earnings or invested capital. Plant-touching businesses generally cannot use federal bankruptcy, so sales run through state receiverships, assignments, or negotiated exits under lender pressure. The prices are sobering. In Oregon’s Chalice Brands receivership the winning bid was $3 million against roughly $35 million of claimed debt. The Grown Rogue package above priced four New York stores and a production facility at about a fifth of retail revenue.

Forced-sale values are low for structural reasons: the buyer pool is limited to people the regulator will approve, specialised build-out has little alternative use, the license may lapse if the process drags, and buyers price in a second approval risk. Benchmarks and method are on valuing a distressed cannabis business. If you own a business heading that way, value it early, while a going-concern sale is still possible.

Broker opinion of value or formal appraisal?

They answer different questions. A broker opinion of value estimates what the market is likely to pay now, using normalized earnings, current buyer behaviour, and transferability. It is what most owners need before deciding whether to sell. A formal appraisal by a credentialed appraiser produces a documented conclusion of value under professional standards, for a defined purpose and date. It is what courts, tax authorities, and some lenders require.

Situation	Usually needed
Deciding whether and when to sell; setting an asking range	Broker opinion of value
Partner buyout under an operating agreement, divorce, litigation	Formal appraisal
Estate and gift tax matters	Formal appraisal
Buyer testing an asking price	Buyer’s own model, sometimes a quality-of-earnings review

The differences, costs, and standards are on appraisal vs broker opinion of value, and dispute settings are on valuation for partner buyouts and disputes.

Try the numbers yourself

The cannabis business valuation calculator combines earnings, tax treatment, and a multiple range into an indicative value. The worked examples page walks through full cases with arithmetic tables for different license types. Owners thinking about a sale should follow with how much is my cannabis business worth.

A broker will typically prepare an opinion of value from three years of financials, tax returns, and state sales reports before any marketing begins; you can ask about one on a free 20-minute intro call. This page is educational. It is not an appraisal, and it is not legal or tax advice. No price is guaranteed.